Historical shareholding details of iShares Micro-Cap ETF holdings in Cognition Therapeutics Inc (CGTX)

Monthly changes of iShares Micro-Cap ETF shareholding in Cognition Therapeutics Inc over the previous months

Month Name Total no. shares held Percent Holding
Mar 31, 2025 Ishares Micro-Cap Etf 71,116 0.11%
Mar 28, 2025 Ishares Micro-Cap Etf 71,116 0.11%
Mar 25, 2025 Ishares Micro-Cap Etf 71,116 0.11%
Feb 28, 2025 Ishares Micro-Cap Etf 71,116 0.12%
Feb 27, 2025 Ishares Micro-Cap Etf 71,116 0.17%
Feb 26, 2025 Ishares Micro-Cap Etf 71,116 0.17%
Jan 31, 2025 Ishares Micro-Cap Etf 73,586 0.18%
Jan 29, 2025 Ishares Micro-Cap Etf 73,586 0.18%
Dec 31, 2024 Ishares Micro-Cap Etf 72,598 0.17%
Dec 30, 2024 Ishares Micro-Cap Etf 72,598 0.17%
Nov 30, 2024 Ishares Micro-Cap Etf 71,610 0.17%
Nov 27, 2024 Ishares Micro-Cap Etf 71,610 0.17%
Oct 31, 2024 Ishares Micro-Cap Etf 71,610 0.18%
Oct 30, 2024 Ishares Micro-Cap Etf 71,610 0.18%
Sep 30, 2024 Ishares Micro-Cap Etf 72,104 0.18%
Sep 27, 2024 Ishares Micro-Cap Etf 72,104 0.18%
Sep 25, 2024 Ishares Micro-Cap Etf 72,104 0.18%
Aug 30, 2024 Ishares Micro-Cap Etf 72,598 0.18%
Aug 28, 2024 Ishares Micro-Cap Etf 72,598 0.18%
Jul 31, 2024 Ishares Micro-Cap Etf 71,610 0.18%
Jul 29, 2024 Ishares Micro-Cap Etf 71,610 0.18%
Jun 13, 2024 Ishares Micro-Cap Etf 51,665 0.13%
May 29, 2024 Ishares Micro-Cap Etf 53,495 0.13%
Apr 26, 2024 Ishares Micro-Cap Etf 50,691 0.13%
Mar 28, 2024 Ishares Micro-Cap Etf 51,711 0.13%
Feb 29, 2024 Ishares Micro-Cap Etf 52,391 0.17%
Feb 28, 2024 Ishares Micro-Cap Etf 52,391 0.17%
Feb 26, 2024 Ishares Micro-Cap Etf 52,051 0.17%
Jan 29, 2024 Ishares Micro-Cap Etf 53,071 0.17%
Dec 27, 2023 Ishares Micro-Cap Etf 48,619 0.16%
Nov 28, 2023 Ishares Micro-Cap Etf 48,307 0.16%
Oct 31, 2023 Ishares Micro-Cap Etf 47,995 0.16%
Sep 27, 2023 Ishares Micro-Cap Etf 49,243 0.16%
Aug 29, 2023 Ishares Micro-Cap Etf 49,555 0.16%
Jul 28, 2023 Ishares Micro-Cap Etf 50,179 0.17%
Jun 21, 2023 Ishares Micro-Cap Etf 37,668 0.13%
May 30, 2023 Ishares Micro-Cap Etf 38,122 0.13%

View all ownership details of Cognition Therapeutics Inc